Shanghai Zhimeng Biopharma Inc. is a fledgling biotechnology startup established in 2017 by experienced professionals from the pharmaceutical industry. Situated in the thriving and abundant Zhangjiang High-Tech Park of Shanghai, China, Zhimeng is focused on the development of treatments for chronic hepatitis B (CHB) and severe neurological conditions with significant unmet medical requirements. Recognizing the intricate nature of chronic hepatitis B virus (HBV) infection, Zhimeng has embraced a comprehensive strategy to address these conditions, targeting the HBV through multiple approaches and restoring the host's immune systems.
Shanghai Zhimeng Biopharma
Headquarters
People's Republic of China